Glaxosmithkline Pharmaceuticals Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

21 Jan 2021 | 04:00 PM

1,520.65
-51.30 (-3.26%)

  • Underperforms Index

    -6.14%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 62.36%

  • More Volatile

    2.16%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 0.43%

  • Not so consistent

    4/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

1,805

1,805.00

1,046

1,046.40

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Glaxosmithkline Pharma Ltd has increased by 56.91% since past 3 Months

  • MF shareholding in Glaxosmithkline Pharma Ltd has decreased by -11.97% since past 3 Months

  • FII shareholding in Glaxosmithkline Pharma Ltd has increased by 204.12% since past 1 Year

  • Glaxosmithkline Pharma Ltd has the 2nd highest P/Bratio according to FY202003 data among stocks in Pharmaceuticals Sector

Loading...